D
Daniel Prieto-Alhambra
Researcher at University of Oxford
Publications - 438
Citations - 11189
Daniel Prieto-Alhambra is an academic researcher from University of Oxford. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 45, co-authored 345 publications receiving 7269 citations. Previous affiliations of Daniel Prieto-Alhambra include Erasmus University Medical Center & Mount Vernon Hospital.
Papers
More filters
Journal ArticleDOI
Global epidemiology of hip fractures: a study protocol using a common analytical platform among multiple countries
Chor-Wing Sing,Tzu-Chieh Lin,Sharon Bartholomew,J. Simon Bell,Corina W Bennett,Kebede Beyene,Pauline Bosco-Lévy,Amy Hai Yan Chan,Manju Chandran,Ching-Lung Cheung,Caroline Y. Doyon,Cécile Droz-Perroteau,Ganga Ganesan,Sirpa Hartikainen,Jenni Ilomäki,Han Eol Jeong,Douglas P. Kiel,Kiyoshi Kubota,Edward Chia Cheng Lai,Jeff Lange,E. Michael Lewiecki,Jiannong Liu,Kenneth K.C. Man,Mirhelen Mendes de Abreu,Nicholas Moore,James O’Kelly,Nobuhiro Ooba,Alma B Pedersen,Daniel Prieto-Alhambra,Ju-Young Shin,Henrik Toft Sørensen,Kelvin Bryan Tan,Kelvin Bryan Tan,Anna-Maija Tolppanen,Katia M.C. Verhamme,Grace Hsin-Min Wang,Sawaeng Watcharathanakij,Hongxin Zhao,Ian C. K. Wong +38 more
TL;DR: In this paper, the authors investigated global trends in hip fracture incidence, mortality and use of postfracture pharmacological treatment across Asia, Oceania, North and South America, and Western and Northern Europe using a unified methodology applied to health records.
Journal ArticleDOI
CPRD GOLD and linked ONS mortality records: Reconciling guidelines.
TL;DR: Recommendations on how to manage mortality data coming from both GOLD and linked ONS, taking into account linkage coverage period, linkage correctness likelihood, linkage regional limitations and data discrepancies between these two datasets are developed.
Journal ArticleDOI
Factors Associated With Type 2 Diabetes Mellitus Treatment Choice Across Four European Countries
Edith M. Heintjes,Jetty A. Overbeek,G C Hall,Daniel Prieto-Alhambra,Francesco Lapi,Niklas Hammar,Irene D. Bezemer +6 more
TL;DR: The results suggest that the main factors driving treatment choice at any stage of intensification were age, hemoglobin A1c, BMI, renal and cardiac morbidity, and treatment history, which were consistent with guidelines on, and contraindications of, specific medications.
Journal ArticleDOI
Unplanned admissions for patients with myeloma in the UK: Low frequency but high costs.
Spyros Kolovos,Guido Nador,Bhuvan Kishore,Matthew Streetly,Neil Rabin,Andrew D Chantry,Andrew D Chantry,Kwee Yong,John Ashcroft,Stella Bowcock,Mark T. Drayson,Karthik Ramasamy,Daniel Prieto-Alhambra,Daniel Prieto-Alhambra,Cyrus Cooper,Cyrus Cooper,Cyrus Cooper,M Kassim Javaid,Rafael Pinedo-Villanueva +18 more
TL;DR: The majority of the hospital admissions are elective, but the highest burden in terms of costs relates to unplanned admissions, with numbers increasing over time.
Journal ArticleDOI
Smoking and COVID-19 Infection and Related Mortality: A Prospective Cohort Analysis of UK Biobank Data
TL;DR: In this article, a prospective study with participants from the UK Biobank cohort was conducted to examine association between smoking and COVID-19 infection and subsequent mortality, and the authors found that older smokers were twice more likely to die from COVID19 than never smokers, possibly mediated by increased risk of chronic conditions or illnesses.